LETROZOLE DEXCEL

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

LETROZOLE

Доступна з:

DEXCEL LTD, ISRAEL

Код атс:

L02BG04

Фармацевтична форма:

FILM COATED TABLETS

Склад:

LETROZOLE 2.5 MG

Адміністрація маршрут:

PER OS

Тип рецепту:

Required

Виробник:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Терапевтична група:

LETROZOLE

Терапевтична области:

LETROZOLE

Терапевтичні свідчення:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Дата Авторизація:

2016-02-29